Targeting the hypoxia-adenosinergic pathway via A2AR antagonists; Toward cancer immunotherapeutics

被引：0
|
作者：
Yuan, Gengyang [1 ]
Hatfield, Stephen [3 ,4 ]
Sitkovsky, Michail [3 ,4 ]
Ondrechen, Mary [2 ]
Jones, Graham [1 ]
机构：
[1] Northeastern Univ, Chem & Chem Biol, Malden, MA USA
[2] Northeastern Univ, Dept Chem, Boston, MA 02115 USA
[3] New England Tissue Protect Inst, Boston, MA USA
[4] Northeastern Univ, Boston, MA 02115 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2015年 / 249卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
124
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Targeting the hypoxia-adenosinergic signaling pathway to improve the adoptive immunotherapy of cancer
    Sitkovsky, Michail
    Ohta, Akio
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 2013, 91 (02): : 147 - 155
  • [2] Targeting the hypoxia-adenosinergic signaling pathway to improve the adoptive immunotherapy of cancer
    Michail Sitkovsky
    Akio Ohta
    [J]. Journal of Molecular Medicine, 2013, 91 : 147 - 155
  • [3] Oxygenation and A2AR blockade to eliminate hypoxia/HIF-1α-adenosinergic immunosuppressive axis and improve cancer immunotherapy
    Halpin-Veszeleiova, Katarina
    Hatfield, Stephen M.
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2020, 53 : 84 - 90
  • [4] A2AR Antagonists Upregulate Expression of GS and GLAST in Rat Hypoxia Model
    Yu, Jun
    Yan, Yan
    Chen, Yiye
    Zheng, Yan
    Yu, Xiaoyan
    Wang, Jialu
    Wang, Yafu
    Wang, Anken
    Kang, Xiaoli
    Cen, Jie
    Dong, Lingyan
    Li, Li
    Zhao, Peiquan
    [J]. BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [5] Targeting the A2AR in cancer; early lessons from the clinic
    Willingham, Stephen B.
    Hotson, Andrew N.
    Miller, Richard A.
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2020, 53 : 126 - 133
  • [6] A2aR antagonists: Next generation checkpoint blockade for cancer immunotherapy
    Leone, Robert D.
    Lo, Ying-Chun
    Powell, Jonathan D.
    [J]. COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2015, 13 : 265 - 272
  • [7] Targeting A2aR in mouse Pten-deficient prostate cancer
    De Velasco, Marco A.
    Kura, Yurie
    Sako, Noriko
    Ando, Naomi
    Sakai, Kazuko
    Nozawa, Masahiro
    Yoshimura, Kazuhiro
    Yoshikawa, Kazuhiro
    Schuller, Alwin
    Nishio, Kazuto
    Uemura, Hirotsugu
    [J]. CANCER RESEARCH, 2020, 80 (16)
  • [8] REVIEW OF TRANSLATIONAL CANCER RESEARCH TARGETING ADENOSINE RECEPTOR A2AR
    Winfield, J.
    Qin, Y.
    Grigoruta, M.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S57 - S57
  • [9] Therapeutic Targeting of Hypoxia-A2-Adenosinergic Pathway in COVID-19 Patients
    Halpin-Veszeleiova, Katarina
    Hatfield, Stephen M.
    [J]. PHYSIOLOGY, 2022, 37 (01) : 46 - 52
  • [10] CD39/CD73/A2AR pathway and cancer immunotherapy
    Chenglai Xia
    Shuanghong Yin
    Kenneth K. W. To
    Liwu Fu
    [J]. Molecular Cancer, 22
12345